FDA approves Intra-Cellullar's schizophrenia drugAnalysts, Antipsychotics, Approvals, Boxed Warning, FDA, FDA/Regulatory, Investors, Mental Disorders, Schizophrenia, SharesIntra-Cellular Therapies Inc.’s lead drug to treat schizophrenia in adults received approval from the U.S. Food and Drug Administration, sending the company’s shares soaring 85 percent. Read more December 23, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-12-23 07:11:192019-12-23 07:11:19FDA approves Intra-Cellullar's schizophrenia drug
